A phase 2 trial of ALIMTA [pemetrexed] plus oxaliplatin administered every 21 days for first-line treatment of patients with advanced colorectal cancer
Latest Information Update: 08 Aug 2006
At a glance
- Drugs Oxaliplatin (Primary) ; Pemetrexed (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 08 Aug 2006 Status change
- 11 Sep 2005 New trial record.